SCHEMBL3580158

SCHEMBL3580158

COc1ccc2c(c1)C(O)(c1ccccc1)C(C(=O)O)=C2c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
PPARG P37231 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
PDK2 Q15119 1/20 0.41
ESR1 P03372 2/20 0.40
PTPN1 P18031 2/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
EDNRA P25101 1/20 0.37
BACE1 P56817 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4654890 0.90 PPARG (0.53) MEN1KMT2APPARGSMN1; SMN2PTPN1
SCHEMBL3572833 0.86 PPARG (0.55) MEN1KMT2APPARGSMN1; SMN2PTPN1
SCHEMBL7532642 0.86 MAPT (0.44) MEN1GAAKMT2ASMN1; SMN2PDK2
SCHEMBL3572635 0.85 PPARG (0.44) MEN1GAAKMT2APPARGSMN1; SMN2
SCHEMBL3571615 0.81 PPARG (0.53) MEN1KMT2APPARGSMN1; SMN2PTPN1
SCHEMBL3571176 0.81 PPARG (0.48) PPARGPDK2
SCHEMBL3570568 0.80 PPARG (0.43) MEN1GAAKMT2APPARGSMN1; SMN2
SCHEMBL3570489 0.77 MEN1 (0.39) MEN1GAAKMT2APPARGSMN1; SMN2
SCHEMBL4657622 0.76 PPARG (0.54) MEN1KMT2APPARGSMN1; SMN2ALDH1A1
SCHEMBL7324013 0.76 PDK2 (0.60) MEN1GAAKMT2APDK2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756036-A4 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RES INST CHEM TECH (KR) 2008-04-16 EP claimed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US claimed
EP-1756036-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-02-28 EP claimed
WO-2005100297-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO claimed
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
EP-1756036-A4 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RES INST CHEM TECH (KR) 2008-04-16 EP disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed
EP-1756036-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-02-28 EP disclosed
WO-2005100297-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof INSR, GPR119, PPARA MEN1 1971/4885GAA 3493/4885KMT2A 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.